Mortality, dementia, and apolipoprotein e genotype in elderly white women in the United States

Journal of the American Geriatrics Society

Volumn 57, Issue 2, 2009, Pages 231-236

  Little, Deborah M ^b   Crooks, Valerie C ^a,b   Petitti, Diana B ^b   Chiu, Vicki ^b   Schellenberg, Gerard D ^c   Slezak, Jeff M ^b   Jacobsen, Steven J ^b  

^a Kaiser Permanente Southern California ^*  (United States)

^b KAISER PERMANENTE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

APOE; Dementia; Genotype

Indexed keywords

APOLIPOPROTEIN E;

AGED; ARTICLE; CONTROLLED STUDY; DEMENTIA; FEMALE; GENE INTERACTION; GENOTYPE; HUMAN; MORTALITY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SURVIVAL RATE; UNITED STATES;

AGED; AGED, 80 AND OVER; APOLIPOPROTEINS E; COGNITION; DEMENTIA; EDUCATIONAL STATUS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HUMANS; MORTALITY; PROPORTIONAL HAZARDS MODELS; UNITED STATES;

EID: 58849118052     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2008.02113.x     Document Type: Article

References (42)

1. Kerr ME, Kraus M. Genetics and the central nervous system: Apolipoprotein E and brain injury. AACN Clin Issues Adv Pract Acute Crit Care 1998 9 : 524 530.
2. Lewis SJ, Brunner EJ. Methodological problems in genetic association studies of longevity-the apolipoprotein E gene as an example. Intl J Epidemiol 2004 33 : 962 970.
3. Tilvis RS, Strandberg TE, Juva K. Apolipoprotein E phenotypes, dementia and mortality in a prospective population sample. J Am Geriatr Soc 1998 46 : 712 715.
4. Hayden KM, Zandi PP, Lyketsos CG et al. Apolipoprotein E genotype and mortality: Findings from the cache county study. J Am Geriatr Soc 2005 53 : 935 942.
5. Juva K, Verkkoniemi A, Viramo P et al. APOE [epsilon]4 does not predict mortality, cognitive decline, or dementia in the oldest old. Neurology 2000 54 : 412 415.
6. Skoog I, Hesse C, Aevarsson O et al. A population study of APOE genotype at the age of 85: Relation to dementia, cerebrovascular disease, and mortality. J Neurol Neurosurg Psychiatry 1998 64 : 37 43.
7. Tschanz JT, Corcoran C, Skoog I et al. Dementia: The leading predictor of death in a defined elderly population (The Cache County Study). Neurology 2004 62 : 1156 1162.
8. Ewbank DC. Mortality differences by APOE genotype estimated from demographic synthesis. Genet Epidemol 2002 22 : 146 155.
9. Rosich-Estrago M, Figuera-Terre L, Mulet-Perez B et al. Dementia and cognitive impairment pattern: Its association with epsilon4 allele of apolipoprotein E gene. Rev Neurol 2004 38 : 801 807.
10. Frikke-Schmidt R, Nordestgaard BG, Thudium D et al. APOE genotype predicts AD and other dementia but not ischemic cerebrovascular disease. Neurology 2001 56 : 194 200.
11. Bennett DA, Wilson RS, Schneider JA et al. Apolipoprotein E ε4 allele, AD pathology, and the clinical expression of Alzheimer's disease. Neurology 2003 60 : 246 252.
12. Kuusisto J, Koivisto K, Kervinen K et al. Association of apolipoprotein E phenotypes with late onset alzheimer's disease: Population based study. BMJ 1994 309 : 636 638.
13. Zhu L, Fratiglioni L, Guo Z et al. Incidence of dementia in relation to stroke and the apolipoprotein E ε4 allele in the very old: Findings from a population-based longitudinal study. Stroke 2000 31 : 53 58.
14. Bartzokis GM, Lu P. Apolipoprotein E genotype and age-related myelin breakdown in healthy individuals: Implications for cognitive decline and dementia. Arch Gen Psychiatry 2006 63 : 63 72.
15. Dal Forno G, Carson KA, Brookmeyer R et al. APOE genotype and survival in men and women with Alzheimer's disease. Neurology 2002 58 : 1045 1050.
16. Olichney JM, Sabbagh MN, Hofstetter CR et al. The impact of apolipoprotein E4 on cause of death in Alzheimer's disease. Neurology 1997 49 : 76 81.
17. Song Y, Stampfer MJ, Liu S. Meta-analysis: Apolipoprotein E genotypes and risk of coronary heart disease. Ann Intern Med 2004 141 : 137 147.
18. McCarron MO, Muir KW, Weir CJ et al. The apolipoprotein E ε4 allele and outcome in cerebrovascular disease. Stroke 1998 29 : 1882 1887.
19. Slattery ML, Sweeney C, Murtaugh M et al. Associations between apoE genotype and colon and rectal cancer. Carcinogenesis 2005 26 : 1422 1429.
20. Martinez-Gonzalez NA, Sudlow CLM. Effects of apolipoprotein E genotype on outcome after ischemic stroke, intracerebral haemorrhage and subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 2006 77 : 1329 1335.
21. Catto AJ, McCormack LJ, Mansfield MW. Apolipoprotein E polymorphism in cerebrovascular disease. Acta Neurol Scand 2000 101 : 399 400.
22. Kuusisto J, Leena M, Kervinen K et al. Apolipoprotein E4 phenotype is not an important risk factor for coronary heart disease and stroke in elderly subjects. Arterioscler Thromb 1995 15 : 1280 1286.
23. Heijmans BT, Slagboom PE, Gussekloo J et al. Association of APOE epsilon2/epsilon3/epsilon4 and promoter gene variants with dementia but not cardiovascular mortality in old age. Am J Med Genet 2002 107 : 201 208.
24. Petitti DB, Buckwalter JG, Crooks VC et al. Prevalence of dementia in users of hormone replacement therapy as defined by prescription data. J Gerontol A Med Sci Biol Sci 2002 57A : M532 M538.
25. Crooks VC, Clark L, Petitti DB et al. Validation of multi-stage telephone-based identification of cognitive impairment and dementia. BMC Neurol 2005 5 : 8.
26. Welsh KS, Breitner JCS, Magruder-Habib KM. Detection of dementia in the elderly using telephone screening of cognitive status. Neuropsychiatry Neuropsychol Behav Neurol 1993 6 : 103 110.
27. Kawas C, Segal J, Stewart WF et al. A validation study of the dementia questionnaire. Arch Neurol 1994 51 : 901 906.
28. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990 31 : 545 548.
29. Commenges D, Letenneur L, Joly P et al. Modeling age-specific risk: Application to dementia. Stat Med 1998 17 : 1973 1988.
30. Korn EL, Graubard BI, Midthune D. Time-to-event analysis of longitudinal follow-up of a survey: Choice of time scale. Am J Epidemiol 1997 145 : 72 80.
31. Jorm AF, Mather KA, Butterworth P et al. APOE genotype and cognitive functioning in a large age-stratified population sample. Neuropsychology 2007 21 : 1 8.
32. Rosvall L, Rizzuto D, Wang HX et al. APOE-related mortality: Effects of dementia, cardiovascular disease and gender. Neurobiol Aging 2008 Jan 29. [Epub ahead of print].
33. Corder EH, Lannfelt L, Viitanen M et al. Apolipoprotein E genotype determines survival in the oldest old (85 years or older) who have good cognition. Arch Neurol 1996 53 : 418 422.
34. Koivisto AM, Lempiainen P, Koivisto K et al. Apolipoprotein E phenotype alone does not influence survival in Alzheimer's disease: A population-based longitudinal study. Neuroepidemiology 2000 19 : 327 332.
35. Frisoni GB, Louhija J, Geroldi C et al. Longevity and the epsilon2 allele of apolipoprotein E: The finnish centenarian study. J Gerontol A Biol Sci Med Sci 2001 56A : M75 M78.
36. Slooter AJ, Cruts M, Broeckhoven C et al. Apolipoprotein E and longevity: The Rotterdam Study. J Am Geriatr Soc 2001 49 : 1258 1259.
37. Farrer LA, Cupples LA, Haines JL et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: Meta-analysis. JAMA 1997 278 : 1349 1356.
38. Blacker D, Haines JL, Rodes L et al. APOE-4 and age at onset of Alzheimer's disease: The NIMH Genetics Initivative. Neurology 1997 48 : 139 147.
39. Gist YN, Hetzel LL. We the People: Aging in the United States. Washington DC : US Census Bureau, 2004.
40. Bretsky PM, Buckwalter JG, Seeman TE et al. Evidence for an interaction between apolipoprotein E genotype, gender and Alzheimer's disease. Alzheimer Dis Assoc Disord 1999 13 : 216 221.
41. Payami H, Zareparsi S, Montee KR et al. Gender differences in apolipoprotein E-associated risk for familial Alzheimer disease: A possible clue to the higher incidence of Alzheimer disease in women. Am J Hum Genet 1996 58 : 803 811.
42. Chodosh JC, Petitti DB, Elliott M et al. Physician recognition of cognitive impairment: Evaluating the need for improvement. J Am Geriatr Soc 2004 52 : 1051 1059.